Sarepta Therapeutics Inc (SRPT)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	1,901,979	1,640,348	1,504,993	1,403,300	1,243,336	1,104,982	1,003,434	975,683	933,013	876,047	835,184	765,786	701,887	645,564	600,082	573,356	540,099	495,074	450,191	407,496
Total assets	US$ in thousands	3,963,170	3,599,930	3,424,260	3,224,380	3,264,580	3,109,710	3,125,890	3,059,790	3,128,370	3,156,150	2,996,850	3,056,150	3,147,970	2,662,220	2,759,070	2,765,230	2,984,720	2,780,660	2,883,040	2,947,390
Total asset turnover		0.48	0.46	0.44	0.44	0.38	0.36	0.32	0.32	0.30	0.28	0.28	0.25	0.22	0.24	0.22	0.21	0.18	0.18	0.16	0.14

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $1,901,979K ÷ $3,963,170K
= 0.48

Total asset turnover is a financial ratio that measures a company's ability to generate revenue from its assets. A higher total asset turnover indicates that the company is more efficient in using its assets to generate sales.

For Sarepta Therapeutics Inc, the total asset turnover has been steadily increasing over the past few years, from 0.14 in March 2020 to 0.48 in December 2024. This indicates that the company has been improving its efficiency in utilizing its assets to generate revenue.

The trend suggests that Sarepta Therapeutics Inc has been able to generate more sales for each dollar of assets it owns over time. This improvement may be attributed to effective management of its assets, increased sales, or a combination of both.

Overall, the increasing trend in total asset turnover signifies that Sarepta Therapeutics Inc has been improving its operational efficiency and productivity in utilizing its assets to drive revenue growth.